EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine
This episode was recorded live from the Ai4 conference podcast pavilion, Sam sat down with Alex Zhavoronkov, Founder & CEO of Insilico Medicine, about what it actually takes to turn AI-generated molecules into approved drugs.
What's Covered:
From Laughed-Out-of-the-Room to 33 Candidates — Alex pitched generative AI for drug design in 2015 and got dismissed. Today: 33 developmental candidates in six years, zero failed toxicity studies, and deals with Eli Lilly, Takeda, Servier, and SK Bio at a pace of nearly one per month.
The Real Bottleneck — "It's not about a story. Many people in our field love to tell a story, but they don't have a single drug in the clinic discovered by AI." Alex's direct take on separating hype from results in AI drug discovery.
A Lucky Breakthrough — The story of how Insilico stumbled onto a novel, non-opioid pain mechanism that outperformed morphine in animal testing — now targeting a $70 billion market.
Why Abu Dhabi — Not for speed, but for geopolitical neutrality. Alex explains why Insilico built a 60-person AI lab in the UAE, and how two drugs now trace their origin to the Middle East for the first time in modern history.
Quantum-Generated Drugs — A December 2025 Nature Biotechnology cover story: a molecule generated on a real IBM quantum computer, validated experimentally, with the University of Toronto.
Pharmaceutical Superintelligence vs. AGI — Where Alex thinks AI drug discovery already stands, and why he draws a hard line between a useful scientific partner and the "conscious AI God" version of AGI.
Key Quote: "In terms of pharmaceutical superintelligence, we're very close to being there. In terms of AGI - the future AI God - we're still not there, and we might never get there."
Connect with Alex:
LinkedIn: https://www.linkedin.com/in/zhavoronkov/
Insilico Medicine Website: https://insilico.com/
Alex's published manuscript about longevity medicine in the Nature journal: https://www.nature.com/articles/s43587-020-00020-4
Follow and subscribe to AsembleAI: Spotify | Apple Podcasts | Amazon Music | iHeart Radio | YouTube | Substack
#Ai4Conference #InsilicoMedicine #DrugDiscoveryAI #Longevity #AsembleAI
More description
This episode was recorded live from the Ai4 conference podcast pavilion, Sam sat down with Alex Zhavoronkov, Founder & CEO of Insilico Medicine, about what it actually takes to turn AI-generated molecules into approved drugs.
What's Covered:
From Laughed-Out-of-the-Room to 33 Candidates — Alex pitched generative AI for drug design in 2015 and got dismissed. Today: 33 developmental candidates in six years, zero failed toxicity studies, and deals with Eli Lilly, Takeda, Servier, and SK Bio at a pace of nearly one per month.
The Real Bottleneck — "It's not about a story. Many people in our field love to tell a story, but they don't have a single drug in the clinic discovered by AI." Alex's direct take on separating hype from results in AI drug discovery.
A Lucky Breakthrough — The story of how Insilico stumbled onto a novel, non-opioid pain mechanism that outperformed morphine in animal testing — now targeting a $70 billion market.
Why Abu Dhabi — Not for speed, but for geopolitical neutrality. Alex explains why Insilico built a 60-person AI lab in the UAE, and how two drugs now trace their origin to the Middle East for the first time in modern history.
Quantum-Generated Drugs — A December 2025 Nature Biotechnology cover story: a molecule generated on a real IBM quantum computer, validated experimentally, with the University of Toronto.
Pharmaceutical Superintelligence vs. AGI — Where Alex thinks AI drug discovery already stands, and why he draws a hard line between a useful scientific partner and the "conscious AI God" version of AGI.
Key Quote: "In terms of pharmaceutical superintelligence, we're very close to being there. In terms of AGI - the future AI God - we're still not there, and we might never get there."
Connect with Alex:
LinkedIn: https://www.linkedin.com/in/zhavoronkov/
Insilico Medicine Website: https://insilico.com/
Alex's published manuscript about longevity medicine in the Nature journal: https://www.nature.com/articles/s43587-020-00020-4
Follow and subscribe to AsembleAI: Spotify | Apple Podcasts | Amazon Music | iHeart Radio | YouTube | Substack
#Ai4Conference #InsilicoMedicine #DrugDiscoveryAI #Longevity #AsembleAI
2026-08-17
40 min
Listen elsewhere
Available Results
Generated results are saved to your library for reuse and search.
No generated results are available for this episode yet.
Transcript
No transcript is available for this episode yet.
No audio file is available for transcript generation.
Chapters
No chapters available.